AstraZenecaAZN
AstraZeneca on podcasts: where it advertises, what it's offering listeners, and what hosts say about it when they're not being paid.
Sponsorships
No ad reads on tracked podcasts in the last 30 days. Hosts are talking about it anyway — see the earned side.
What hosts are saying
Most mentioned on
In their words
“Astroenica has just invested $2 billion in a US biotech called Summit Therapeutics and they are collaborating on a really promising new cancer medicine. Second angle is that Astroenica had stayed away from this area where Summit is active.”
AstraZeneca is discussed substantively regarding their $2 billion investment in Summit Therapeutics without explicit praise or criticism.
▶ Hear it“They signed $2 billion equity investment in Summit Therapeutics. That's one angle that's a little bit different to the usual partnership deals that you see. Second angle is that AstraZeneca had stayed away from this area where summit is active.”
Company is discussed substantively regarding its $2 billion equity investment in Summit Therapeutics and strategic approach to bispecific antibodies, without positive or negative evaluation.
▶ Hear it“Astroenica agreed to invest $2 billion in Summit Therapeutics to collaborate on a promising new cancer medication that could be combined with what Astroenica is doing in terms of treatments.”
Mentioned in context of a $2 billion investment in Summit Therapeutics for cancer medication collaboration.
▶ Hear itThe full picture
A weekly email with where each one advertised and what hosts said about them. Free.